Management of multifactorial idiopathic epilepsy in EL mice with caloric restriction and the ketogenic diet: Role of glucose and ketone bodies

Nutrition and Metabolism

Volumn 1, Issue , 2004, Pages

  Mantis, John G ^a   Centeno, Nicole A ^a   Todorova, Mariana T ^a   McGowan, Richard ^a   Seyfried, Thomas N ^a  

^a BOSTON COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBUTYRIC ACID; GLUCOSE; KETONE BODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT THERAPY; ARTICLE; BODY WEIGHT; CALORIC RESTRICTION; CONTROLLED STUDY; DISEASE CONTROL; ENERGY; EPILEPSY; FEMALE; GLUCOSE BLOOD LEVEL; INTERMETHOD COMPARISON; KETOGENIC DIET; MALE; MOUSE; NERVE CELL; NONHUMAN; PREDICTION; REACTION TIME; SEIZURE SUSCEPTIBILITY; STANDARDIZATION; STATISTICAL SIGNIFICANCE;

EID: 15444371484     PISSN: 17437075     EISSN: None     Source Type: Journal    
DOI: 10.1186/1743-7075-1-11     Document Type: Article

References (72)

1. Engel J. Jr., Pedley TA: Introduction: What is Epilepsy? In Epilepsy: A Comprehensive Textbook Volume 1. Edited by: Engel J Jr and Pedley T A. New York, Lipponcott-Raven; 1997:1-10.
2. Seyfried TN, Todorova M: Experimental models of epilepsy. In The Epilepsies: Etiologies and Prevention Edited by: Kotagal P and Luders HO. New York, Academic Press; 1999:527-542.
3. Hauser WA: Incidence and prevalence. In Epilepsy: A Comprehensive Textbook Volume 1. Edited by: Engel J Jr and Pedley T A. New York, Lippincott-Raven; 1997:47-57.
4. Baumann RJ: Classification and population studies of epilepsy. In Genetic basis of the epilepsies Edited by: Anderson VE, Hauser WA, Penry JK and Sing CF. New York, Raven Press; 1982:11-20.
5. Wolf P: Historical aspects: the concept of idiopathy. In Idiopathic generalized epilepsies: clinical, experimental, and genetic aspects Edited by: Malafosse A, Genton P, Hirsch E, Marescaux C, Broglin D and Bernasconi R. London, John Libbey & Company Ltd.; 1994:3-6.
6. Todorova MT, Burwell TJ, Seyfried TN: Environmental risk factors for multifactorial epilepsy in EL mice. Epilepsia 1999, 40:1697-1707.
7. Berkovic SF: Genetics of epilepsy syndromes. In Epilepsy: A comprehensive textbook Volume 3. Edited by: Engel JJ and Pedley T A. Philadelphia, Lippincott-Raven; 1998:217-224.
8. Naruse H, Kurokawa M: The beginnings of studies on EL mice. Neurosciences 1992, 18 (Suppl. 2):1-3.
9. Frankel WN, Johnson EW, Lutz CM: Congenic strains reveal effects of the epilepsy quantitative locus, El2, separate from other El loci. Mamm Genome 1995, 6:839-843.
10. Seyfried TN, Poderycki MJ, Todorova MT: Genetics of the EL mouse: a multifactorial epilepsy model. In Genetics of Focal Epilepsies Edited by: Genton P, Berkovic S F, Hirsch E and Marescaux C. London, John Libbey & Company Ltd.; 1999:229-238.
11. Uchibori M, Saito K, Yokoyama S, Sakamoto Y, Suzuki H, Tsuji T, Suzuki K: Foci identification of spike discharges in the EEGs of sleeping El mice based on the electric field model and wavelet decomposition of multi monopolar derivations. J Neurosci Methods 2002, 117:51-63.
12. Ishida N, Kasamo K, Nakamoto Y, Suzuki J: Epileptic seizure of El mouse initiates at the parietal cortex: depth EEG observation in freely moving condition using buffer amplifier. Brain Res 1993, 608:52-57.
13. Suzuki J, Kasamo K, Ishida N, Murashima YL: Initiation, propagation and generalization of paroxysmal discharges in an epileptic mutant animal. Jpn J Psychiatry Neurol 1991, 45:271-274.
14. Suzuki J, Nakamoto Y: Seizure patterns and electroencephalograms of El mouse. Electroencephalogr Clin Neurophysiol 1977, 43:299-311.
15. Suzuki J: Paroxysmal discharges in the electroencephalogram of the El mouse. Experientia 1976, 32:336-338.
16. Sato H: The development of EEG background activities in El mouse. Folia Psychiatr Neurol Jpn 1985, 39:581-587.
17. Nakano H, Saito K, Suzuki K: Chronic implantation technique for monopolar EEG monitoring of epileptic seizures in mice. Brain Res Bull 1994, 35:261-268.
18. Brigande JV, Wieraszko A, Albert MD, Balkema GW, Seyfried TN: Biochemical correlates of epilepsy in the El mouse: analysis of glial fibrillary acidic protein and gangliosides. J Neurochem 1992, 58:752-760.
19. Drage MG, Holmes GL, Seyfried TN: Hippocampal neurons and glia in epileptic EL mice. J Neurocytol 2002, 31:681-692.
20. Todorova M, Tandon P, Madore RA, Stafstrom CE, Seyfried TN: Ketogenic diet inhibits epileptogenesis in EL mice: a genetic model for idiopathic epilepsy. Epilepsia 2000, 41:933-940.
21. Greene AE, Todorova MT, McGowan R, Seyfried TN: Caloric restriction inhibits seizure susceptibility in epileptic EL mice by reducing blood glucose. Epilepsia 2001, 42:1371-1378.
22. Nagatomo I, Akasaki Y, Nagase F, Nomaguchi M, Takigawa M: Relationships between convulsive seizures and serum and brain concentrations of phenobarbital and zonisamide in mutant inbred strain EL mouse. Brain Res 1996, 731:190-198.
23. Poderycki MJ, Simoes JM, Todorova M, Neumann PE, Seyfried TN: Environmental influences on epilepsy gene mapping in EL mice. J Neurogenet 1998, 12:67-86.
24. Browne TR, Holmes GL: Epilepsy. N Engl J Med 2001, 344:1145-1151.
25. Freeman JM, Freeman JB, Kelly MT: The Ketogenic Diet: A Treatment for Epilepsy. 3rd edition. New York, Demos; 2000:236.
26. Jallon P: The problem of intractability: the continuing need for new medical therapies in epilepsy. Epilepsia 1997, 38 (Suppl 9):S37-42.
27. Lennox WG: Epilepsy and Related Disorders. Volume 1. Boston, Little, Brown and Company; 1960:1168.
28. Lennox WG, Cobb S: Studies in epilepsy VIII. The clinical effect of fasting. Arch Neurol Psychiat 1928, 20:771-779.
29. Greene AE, Todorova MM, Seyfried TN: Perspectives on the metabolic management of epilepsy through dietary reduction of glucose and elevation of ketone bodies. J Neurochem 2003, 86:529-537.
30. Wilder RM: The effects of ketonemia on the course of epilepsy. Mayo Clinic Proc 1921, 2:307-308.
31. Stafstrom CE, Bough KJ: The ketogenic diet for the treatment of epilepsy: a challenge for nutritional neuroscientists. Nutr Neurosci 2003, 6:67-79.
32. Peterman MG: The ketogenic diet. J Amer Med Assoc 1928, 90:1427-1429.
33. Harney JP, Madara J, I'Anson H: Effects of acute inhibition of fatty acid oxidation on latency to seizure and concentrations of beta hydroxybutyrate in plasma of rats maintained on calo-rie restriction and/or the ketogenic diet. Epilepsy Res 2002, 49:239-246.
34. Likhodii SS, Musa K, Mendonca A, Dell C, Burnham WM, Cunnane SC: Dietary fat, ketosis, and seizure resistance in rats on the ketogenic diet. Epilepsia 2000, 41:1400-1410.
35. Bough KJ, Chen RS, Eagles DA: Path analysis shows that increasing ketogenic ratio, but not beta-hydroxybutyrate, elevates seizure threshold in the Rat. Dev Neurosci 1999, 21:400-406.
36. Thio LL, Wong M, Yamada KA: Ketone bodies do not directly alter excitatory or inhibitory hippocampal synaptic transmission. Neurology 2000, 54:325-331.
37. Appleton DB, DeVivo DC: An animal model for the ketogenic diet. Epilepsia 1974, 15:211-227.
38. Seyfried TN, Greene AE, Todorova MM: Caloric restriction and epilepsy: Historical perspectives, relationship to the ketogenic diet, and analysis in epileptic EL mice. In Epilepsy and the Ketogenic Diet Edited by: Stafstrom C E and Rho J M. Totowa, NJ, Humana Press Inc.; 2004:247-264.
39. Weindruch R, Walford RL: The retardation of aging and disease by dietary restriction. Springfield, IL, Thomas; 1988:436.
40. Duan W, Guo Z, Jiang H, Ware M, Li XJ, Mattson MP: Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice. Proc Natl Acad Sci U S A 2003, 100:2911-2916.
41. Bough KJ, Valiyil R, Han FT, Eagles DA: Seizure resistance is dependent upon age and calorie restriction in rats fed a ketogenic diet. Epilepsy Res 1999, 35:21-28.
42. McIlwain H: Cerebral energy metabolism and membrane phenomena. In Basic Mechanisms of the Epilepsies Edited by: Jasper H H, Ward A A Jr and Pope A. Boston, Little, Brown, and Co.; 1969:83-103.
43. Meldrum B, Chapman A: Epileptic seizures and epilepsy. In Basic Neurochemistry: Molecular, Cellular and Medical Aspects 6th edition. Edited by: Siegel G J, Agranoff B W, Albers R W, Fisher S K and Uhler M D. New York, Lippincott-Raven; 1999:755-768.
44. Cornford EM, Shamsa K, Zeitzer JM, Enriquez CM, Wilson CL, Behnke EJ, Fried I, Engel J: Regional analyses of CNS microdialysate glucose and lactate in seizure patients. Epilepsia 2002, 43:1360-1371.
45. Schwechter EM, Veliskova J, Velisek L: Correlation between extracellular glucose and seizure susceptibility in adult rats. Ann Neurol 2003, 53:91-101.
46. Clarke DD, Sokoloff L: Circulation and energy metabolism of the brain. In Basic Neurochemistry: Molecular, Cellular and Medical Aspects 6th edition. Edited by: Siegel G J, Agranoff B W, Albers R W, Fisher S K and Uhler M D. New York, Lippincott-Raven; 1999:637-669.
47. Cornford EM, Nguyen EV, Landaw EM: Acute upregulation of blood-brain barrier glucose transporter activity in seizures. Am J Physiol Heart Circ Physiol 2000, 279:H1346-54.
48. Ackermann RF, Lear JL: Glycolysis-induced discordance between glucose metabolic rates measured with radiolabeled fluorodeoxyglucose and glucose. J Cereb Blood Flow Metab 1989, 9:774-785.
49. Meric P, Barrere B, Peres M, Gillet B, Berenger G, Beloeil JC, Seylaz J: Effects of kainate-induced seizures on cerebral metabolism: a combined 1H and 31P NMR study in rat. Brain Res 1994, 638:53-60.
50. Knowlton RC, Abou-Khalil B, Sawrie SM, Martin RC, Faught RE, Kuzniecky RI: In vivo hippocampal metabolic dysfunction in human temporal lobe epilepsy. Arch Neurol 2002, 59:1882-1886.
51. Ikemoto A, Bole DG, Ueda T: Glycolysis and glutamate accumulation into synaptic vesicles. Role of glyceraldehyde phosphate dehydrogenase and 3-phosphoglycerate kinase. J Biol Chem 2003, 278:5929-5940.
52. Li X, Yokono K, Okada Y: Phosphofructokinase, a glycolytic regulatory enzyme has a crucial role for maintenance of synaptic activity in guinea pig hippocampal slices. Neurosci Lett 2000, 294:81-84.
53. Ting YL, Degani H: Energetics and glucose metabolism in hippocampal slices during depolarization: 31P and 13C NMR studies. Brain Res 1993, 610:16-23.
54. Vielhaber S, Von Oertzen JH, Kudin AF, Schoenfeld A, Menzel C, Biersack HJ, Kral T, Elger CE, Kunz WS: Correlation of Hippocampal Glucose Oxidation Capacity and Interictal FDG-PET in Temporal Lobe Epilepsy. Epilepsia 2003, 44:193-199.
55. Mantis JG, Centeno N, Todorova MT, McGowan R, Seyfried TN: Metabolic control of epilepsy in adult EL mice with the ketogenic diet and caloric restriction. Epilepsia 2003, 44: 64-65.
56. Hoag WG, Dickie MM: Nutrition. In Biology of the Laboratory Mouse 2nd edition. Edited by: Green E L. New York, Dover; 1968.
57. Keenan KP, Ballam GC, Soper KA, Laroque P, Coleman JB, Dixit R: Diet, caloric restriction, and the rodent bioassay. Toxicol Sci 1999, 52:24-34.
58. Eagles DA, Boyd SJ, Kotak A, Allan F: Calorie restriction of a highcarbohydrate diet elevates the threshold of PTZ-induced seizures to values equal to those seen with a ketogenic diet. Epilepsy Res 2003, 54:41-52.
59. Bouzier-Sore AK, Merle M, Magistretti PJ, Pellerin L: Feeding active neurons: (re)emergence of a nursing role for astrocytes. J Physiol Paris 2002, 96:273-282.
60. Kasischke KA, Vishwasrao HD, Fisher PJ, Zipfel WR, Webb WW: Neural activity triggers neuronal oxidative metabolism followed by astrocytic glycolysis. Science 2004, 305:99-103.
61. Owen OE, Morgan AP, Kemp HG, Sullivan JM, Herrera MG, Cahill G. F., Jr.: Brain metabolism during fasting. J Clin Invest 1967, 46:1589-1595.
62. Colmers WF, El Bahh B: Neuropeptide Y and Epilepsy. Epilepsy Curr 2003, 3:53-58.
63. Mazarati A, Wasterlain CG: Anticonvulsant effects of four neuropeptides in the rat hippocampus during self-sustaining status epilepticus. Neurosci Lett 2002, 331:123-127.
64. Husum H, Bolwig TG, Sanchez C, Mathe AA, Hansen SL: Levetiracetam prevents changes in levels of brain-derived neurotrophic factor and neuropeptide Y mRNA and of Y1- and Y5-like receptors in the hippocampus of rats undergoing amygdala kindling: implications for antiepileptogenic and moodstabilizing properties. Epilepsy Behav 2004, 5:204-215.
65. Richichi C, Lin EJ, Stefanin D, Colella D, Ravizza T, Grignaschi G, Veglianese P, Sperk G, During MJ, Vezzani A: Anticonvulsant and antiepileptogenic effects mediated by adeno-associated virus vector neuropeptide Y expression in the rat hippocampus. J Neurosci 2004, 24:3051-3059.
66. Yudkoff M, Daikhin Y, Nissim I, Lazarow A, Nissim I: Ketogenic diet, amino acid metabolism, and seizure control. J Neurosci Res 2001, 66:931-940.
67. Veech RL, Chance B, Kashiwaya Y, Lardy HA, Cahill G. F., Jr.: Ketone bodies, potential therapeutic uses. IUBMB Life 2001, 51:241-247.
68. Kaur G, Kaur K: Effect of acute starvation on monoamine oxidase and Na+,K(+)-ATPase activity in rat brain. Mol Chem Neuropathol 1990, 13:175-183.
69. Schwartzkroin PA: Mechanisms underlying the anti-epileptic efficacy of the ketogenic diet. Epilepsy Res 1999, 37:171-180.
70. Todorova MT, Dangler CA, Drage MG, Sheppard BJ, Fox JG, Seyfried TN: Sexual dysfunction and sudden death in epileptic male EL mice: inheritance and prevention with the ketogenic diet. Epilepsia 2003, 44:25-31.
71. Williamson DH, Mellanby J, Krebs HA: Enzymic determination of D(-)-beta-hydroxybutyric acid and acetoacetic acid in blood. Biochem J 1962, 82:90-96.
72. Lang TA, Secic M: How to Report Statistics in Medicine. Philadelphia, Amer. College Physicians; 1997.